Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.

MLA

Bibawi, S., et al. “Thiotepa, Busulfan, and Cyclophosphamide as a Preparative Regimen for Allogeneic Transplantation for Advanced Myelodysplastic Syndrome and Acute Myelogenous Leukemia.” American Journal of Hematology, vol. 67, no. 4, Aug. 2001, pp. 227–33. EBSCOhost, https://doi.org/10.1002/ajh.1121.

APA

Bibawi, S., Abi-Said, D., Fayad, L., Anderlini, P., Ueno, N. T., Mehra, R., Khouri, I., Giralt, S., Gajewski, J., Donato, M., Claxton, D., Braunschweig, I., van Besien, K., Andreeff, M., Andersson, B. S., Estey, E. H., Champlin, R., & Przepiorka, D. (2001). Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia. American Journal of Hematology, 67(4), 227–233. https://doi.org/10.1002/ajh.1121

Chicago

Bibawi, S, D Abi-Said, L Fayad, P Anderlini, N T Ueno, R Mehra, I Khouri, et al. 2001. “Thiotepa, Busulfan, and Cyclophosphamide as a Preparative Regimen for Allogeneic Transplantation for Advanced Myelodysplastic Syndrome and Acute Myelogenous Leukemia.” American Journal of Hematology 67 (4): 227–33. doi:10.1002/ajh.1121.